SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon reports 14% rise in Q2 consolidated net profit

25 Oct 2013 Evaluate

Biocon has reported results for the second quarter ended September 30, 2013.

The company has reported 7.99% rise in its net profit at Rs 95.42 crore for the quarter as compared to Rs 88.36 crore for the same quarter in the previous year. Total income of the company has increased by 11.98% at Rs 579.71 crore for quarter under review as compared to Rs 517.75 crore for the quarter ended September 30, 2012.

On consolidated basis, the group’s net profit for the quarter under review grew 13.94% at Rs 102.15 crore against Rs 89.65 crore in the second quarter of previous fiscal. Group’s total income from operation rose 17.23% at Rs 752.54 crore for the quarter from Rs 641.94 crore in the similar quarter of previous year.

Biocon Share Price

362.70 4.20 (1.17%)
21-Apr-2026 12:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1220.50
Cipla 1232.75
Zydus Lifesciences 927.80
Lupin 2321.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×